NexImmune Inc. announced the appointment of Leena Gandhi, M.D., Ph.D., Director for the Center of Therapeutic Innovation at Dana-Farber Cancer Institute, to its Board of Directors as a Non-Executive Director.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.42 USD | -0.58% | -5.00% | +54.05% |
Apr. 17 | North American Morning Briefing : Stock Futures -2- | DJ |
Apr. 16 | NexImmune, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+54.05% | 4.72M | |
+8.63% | 114B | |
+10.88% | 104B | |
-12.56% | 22.41B | |
-0.52% | 22.28B | |
-5.80% | 19.07B | |
-37.36% | 18B | |
-5.29% | 17.89B | |
+7.26% | 14.28B | |
+36.51% | 12.55B |
- Stock Market
- Equities
- NEXI Stock
- News NexImmune, Inc.
- NexImmune Inc. Appoints Leena Gandhi to Board of Directors as a Non-Executive Director